| 1 |
Brian Martin |
Lightkeeper |
9 |
| 2 |
Kenneth W. Duncan |
Epizyme |
7 |
| 3 |
Youzhi Li |
Covidien Lp |
6 |
| #4 |
Magali B. Hickey |
Alkermes Pharma Ireland Limited |
5 |
| #4 |
Peter S. Dawson |
Ineoquesto Technologies |
5 |
| #4 |
Kevin Leary |
Reebok International Limited |
5 |
| #7 |
William McInnis |
Reebok International Limited |
4 |
| #7 |
Ward Fritz |
Cosco Management |
4 |
| #9 |
Joey L. Methot |
Merck |
3 |
| #9 |
Murray R. Cantor |
IBM |
3 |
| #9 |
Mushegh Hakhinian |
Intralinks |
3 |
| #12 |
James Aggen |
Achaogen |
2 |
| #12 |
Robert F. Praino, Jr. |
Qd Vision |
2 |
| #12 |
Andrei Vertikov |
Tomophase |
2 |
| #12 |
Brian S. Ahern |
US Air Force |
2 |
| #12 |
Hamid Davoudi |
Boston Scientific Scimed |
2 |
| #17 |
Russell L. Agrusa |
Iconics |
1 |
| #17 |
Steve J. Ganem |
Witricity |
1 |
| #17 |
Gregory Radner |
Thomson Reuters Global Resources Unlimited |
1 |
| #17 |
Joseph D Salami, Jr. |
— |
1 |
| #17 |
William Querbes |
Alnylam Pharmaceuticals |
1 |
| #17 |
Mohamed H. Sayegh |
Brigham and Women's Hospital |
1 |
| #17 |
Matthew T. Sullivan |
Schlumberger Technology |
1 |
| #17 |
Daniel E. Glenn |
Luxtron |
1 |
| #17 |
Donald S. Baim |
Mitralign |
1 |
| #17 |
Harmon Zuccola |
Vertex Pharmaceuticals Incorporated |
1 |
| #17 |
Ronald N. Reece |
Axcelis Technologies |
1 |
| #17 |
David Eric Abramowitz |
— |
1 |
| #17 |
Xiaodong Tao |
GE |
1 |
| #17 |
Andrey Vertikov |
Tomophase |
1 |
| #17 |
Shane Rice |
Emc |
1 |
| #17 |
Peter D. Muellers |
The Mathworks |
1 |
| #17 |
Vinay Iyengar |
Netlogic Microsystems |
1 |